Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
39.62
+0.19 (0.48%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Mirum Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 222.5 | 286.33 | 28 | 31.34 | 142.09 | Upgrade
|
| Short-Term Investments | 57.81 | - | 123.72 | 125.2 | 89.73 | Upgrade
|
| Cash & Short-Term Investments | 280.32 | 286.33 | 151.72 | 156.54 | 231.82 | Upgrade
|
| Cash Growth | -2.10% | 88.72% | -3.08% | -32.47% | 98.71% | Upgrade
|
| Accounts Receivable | 78.29 | 67.97 | 23.99 | 3.27 | - | Upgrade
|
| Other Receivables | - | - | - | 0.3 | - | Upgrade
|
| Receivables | 78.29 | 67.97 | 23.99 | 3.57 | - | Upgrade
|
| Inventory | 22.4 | 22.31 | 5.57 | 1.51 | - | Upgrade
|
| Prepaid Expenses | 11.78 | 10.94 | 8.95 | 4.97 | 4.53 | Upgrade
|
| Total Current Assets | 392.79 | 387.54 | 190.23 | 166.59 | 236.35 | Upgrade
|
| Property, Plant & Equipment | 9.81 | 1.99 | 2.35 | 2.55 | 3.24 | Upgrade
|
| Long-Term Investments | 12.53 | - | - | 4.98 | - | Upgrade
|
| Other Intangible Assets | 249.82 | 252.93 | 58.95 | 18.74 | - | Upgrade
|
| Other Long-Term Assets | 5.81 | 4.17 | 101.38 | 101.79 | 1.27 | Upgrade
|
| Total Assets | 670.75 | 646.62 | 352.91 | 294.65 | 240.86 | Upgrade
|
| Accounts Payable | 14.62 | 7.42 | 8.69 | 9.17 | 3.15 | Upgrade
|
| Accrued Expenses | 72.86 | 54.89 | 34.73 | 24.42 | 13.41 | Upgrade
|
| Current Portion of Leases | 1.71 | 1.1 | 0.93 | 0.71 | 0.64 | Upgrade
|
| Other Current Liabilities | 37.36 | 23.65 | 20.37 | 8.3 | 1.26 | Upgrade
|
| Total Current Liabilities | 126.55 | 87.06 | 64.73 | 42.6 | 18.46 | Upgrade
|
| Long-Term Debt | 308.08 | 306.42 | - | - | - | Upgrade
|
| Long-Term Leases | 7.97 | 0.62 | 1.26 | 1.9 | 2.63 | Upgrade
|
| Other Long-Term Liabilities | 2.51 | 3.85 | 144.88 | 129.94 | 47.68 | Upgrade
|
| Total Liabilities | 445.11 | 397.95 | 210.87 | 174.44 | 68.77 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 870.19 | 803.26 | 535.07 | 377.4 | 345.18 | Upgrade
|
| Retained Earnings | -644.18 | -556.24 | -392.82 | -257.16 | -173.17 | Upgrade
|
| Comprehensive Income & Other | -0.37 | 1.64 | -0.22 | -0.04 | 0.08 | Upgrade
|
| Total Common Equity | 225.64 | 248.67 | 142.04 | 120.21 | 172.1 | Upgrade
|
| Shareholders' Equity | 225.64 | 248.67 | 142.04 | 120.21 | 172.1 | Upgrade
|
| Total Liabilities & Equity | 670.75 | 646.62 | 352.91 | 294.65 | 240.86 | Upgrade
|
| Total Debt | 317.76 | 308.14 | 2.19 | 2.61 | 3.26 | Upgrade
|
| Net Cash (Debt) | -37.45 | -21.82 | 149.53 | 153.93 | 228.56 | Upgrade
|
| Net Cash Growth | - | - | -2.86% | -32.65% | 102.24% | Upgrade
|
| Net Cash Per Share | -0.79 | -0.53 | 4.40 | 5.08 | 9.05 | Upgrade
|
| Filing Date Shares Outstanding | 49.01 | 47 | 37.95 | 31.73 | 30.42 | Upgrade
|
| Total Common Shares Outstanding | 48.34 | 46.72 | 36.96 | 30.58 | 29.78 | Upgrade
|
| Working Capital | 266.24 | 300.48 | 125.5 | 124 | 217.89 | Upgrade
|
| Book Value Per Share | 4.67 | 5.32 | 3.84 | 3.93 | 5.78 | Upgrade
|
| Tangible Book Value | -24.18 | -4.26 | 83.08 | 101.47 | 172.1 | Upgrade
|
| Tangible Book Value Per Share | -0.50 | -0.09 | 2.25 | 3.32 | 5.78 | Upgrade
|
| Machinery | 1.64 | 0.91 | 0.6 | 0.2 | 0.3 | Upgrade
|
| Leasehold Improvements | 0.2 | 1.3 | 1.31 | 1.48 | 1.29 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.